Correlation Between Allakos and Day One
Can any of the company-specific risk be diversified away by investing in both Allakos and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allakos and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allakos and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Allakos and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allakos with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allakos and Day One.
Diversification Opportunities for Allakos and Day One
Very weak diversification
The 3 months correlation between Allakos and Day is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Allakos and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Allakos is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allakos are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Allakos i.e., Allakos and Day One go up and down completely randomly.
Pair Corralation between Allakos and Day One
Given the investment horizon of 90 days Allakos is expected to under-perform the Day One. In addition to that, Allakos is 2.11 times more volatile than Day One Biopharmaceuticals. It trades about -0.12 of its total potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.09 per unit of volatility. If you would invest 1,481 in Day One Biopharmaceuticals on September 3, 2024 and sell it today you would lose (88.00) from holding Day One Biopharmaceuticals or give up 5.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allakos vs. Day One Biopharmaceuticals
Performance |
| Timeline |
| Allakos |
| Day One Biopharmaceu |
Allakos and Day One Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allakos and Day One
The main advantage of trading using opposite Allakos and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allakos position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.| Allakos vs. Apellis Pharmaceuticals | Allakos vs. Blueprint Medicines Corp | Allakos vs. Day One Biopharmaceuticals | Allakos vs. Atara Biotherapeutics |
| Day One vs. DiaMedica Therapeutics | Day One vs. Lyra Therapeutics | Day One vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |